Preclinical evaluation of the novel BTK inhibitor acalabrutinib in canine models of B-cell non-hodgkin lymphoma

Bonnie K. Harrington, Heather L. Gardner, Raquel Izumi, Ahmed Hamdy, Wayne Rothbaum, Kevin R. Coombes, Todd Covey, Allard Kaptein, Michael Gulrajani, Bart Van Lith, Cecile Krejsa, Christopher C. Coss, Duncan S. Russell, Xiaoli Zhang, Bridget K. Urie, Cheryl A. London, John C. Byrd, Amy J. Johnson, William C. Kisseberth

Research output: Contribution to journal › Article › peer-review